248 Participants Needed

mHealth App for Prostate Cancer Survivors

Recruiting at 2 trial locations
MA
SD
Overseen BySabrina Dickey, PhD, RN
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: University of Oklahoma
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new mobile health app designed to help Black men with prostate cancer manage their health and improve their quality of life. The study aims to assess the app's usability and gather feedback for improvement. Participants are divided into two groups: one uses the app, while the other does not. Ideal candidates are Black men diagnosed with prostate cancer within the last five years who own a smartphone. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance future health management tools.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this mHealth app is safe for prostate cancer survivors?

Research has shown that mobile health (mHealth) apps are generally safe and easy to use. In studies of similar apps for issues like gambling addiction, users found them helpful and safe, with no major problems reported. This suggests that using an mHealth app for prostate cancer survivors is likely safe as well. Although specific safety data for this exact app is not available, mHealth technology for prostate cancer has been studied before without any safety concerns. This trial focuses on ensuring the app is user-friendly and meets patients' needs, rather than testing for safety issues.12345

Why are researchers excited about this trial?

The mHealth app is unique because it offers a personalized, digital approach to supporting prostate cancer survivors, particularly focusing on Black men who are either undergoing treatment or have completed it. Unlike traditional treatments that might focus solely on medication or surgery, this app provides tailored health management and support directly through a smartphone, making it accessible and convenient. Researchers are excited about this trial because it explores how digital health tools can enhance the quality of life and health outcomes for prostate cancer survivors by offering continuous support and monitoring beyond the hospital setting.

What evidence suggests that this mHealth app is effective for prostate cancer survivors?

Research has shown that mobile health (mHealth) apps can help manage health conditions by providing timely support and information. In this trial, participants in the intervention group will access an mHealth app designed for Black men with prostate cancer. Studies have found that such apps improve quality of life by offering culturally appropriate support and helping manage treatment side effects, enhancing overall well-being. Although direct evidence on this specific app is limited, the success of similar mHealth apps suggests potential benefits. Early findings indicate that these apps can be helpful for prostate cancer survivors.12345

Who Is on the Research Team?

MA

Motolani Adedipe, PhD, DPh, MS

Principal Investigator

University of Oklahoma

Are You a Good Fit for This Trial?

This trial is for Black individuals who are either currently undergoing treatment for prostate cancer or have survived it. The study aims to include those who can provide feedback on a mobile health app designed specifically for them.

Inclusion Criteria

I am a Black man, within 5 years of my prostate cancer diagnosis, and I was born in the US, Caribbean, or Africa.

Exclusion Criteria

I am a man and I do not own a smartphone.
I am a man not of Caucasian descent.
I have never been diagnosed with prostate cancer.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants use the mHealth app at home, completing daily symptom surveys and weekly mood assessments

12 months
Online surveys at 0, 3, 6, 9, and 12 months

Follow-up

Participants are monitored for quality of life improvements using the FACT-P survey

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • mHealth App
Trial Overview The focus of the trial is on a mobile health (mHealth) app tailored for Black prostate cancer patients and survivors. Participants will use the app and complete surveys to assess its impact on their quality of life.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment2 Interventions
Group II: Control groupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Oklahoma

Lead Sponsor

Trials
484
Recruited
95,900+

Published Research Related to This Trial

A study evaluated 457 mobile health applications (MHAs) for prostate cancer antigen (PSA) dosage, finding that only 24 met the criteria for quality assessment, with an overall mean score below the acceptable threshold.
The quality of these apps was generally low, but well-developed MHAs could enhance PSA screening efforts and improve access to care, especially for patients in rural areas, potentially leading to earlier detection and treatment of prostate cancer.
A mobile health application for prostate cancer antigen dosage: is it time to say goodbye to classic screening methods?Di Bello, F., di Mauro, E., Fusco, GM., et al.[2023]
The app-based intervention 'Mila Blooms' was developed to promote healthy eating and physical activity among adolescent survivors of childhood cancer, and it showed high participant retention (93.8%) over an 8-week period, indicating strong feasibility.
While the initial evaluation did not show significant behavior change, participants reported positive experiences with the app, highlighting its ease of use and enjoyment, and there were no adverse side effects, suggesting it is a safe and appealing option for health promotion.
Mila Blooms: A Mobile Phone Application and Behavioral Intervention for Promoting Physical Activity and a Healthy Diet Among Adolescent Survivors of Childhood Cancer.Fuemmeler, BF., Holzwarth, E., Sheng, Y., et al.[2021]
The CHAT intervention, a 4-week mobile health program for African American breast cancer survivors, demonstrated high participant engagement and acceptability, with 85% of participants reporting positive behavior changes.
Participants in the intervention group significantly reduced their sedentary time by 4.37 hours per day and decreased fast food intake by 1.5 servings, indicating the potential effectiveness of mobile technology in improving health behaviors among this population.
A Pilot and Feasibility Mobile Health Intervention to Support Healthy Behaviors in African American Breast Cancer Survivors.Allicock, M., Kendzor, D., Sedory, A., et al.[2022]

Citations

Large Grant: “Don't Go There: A Geospatial mHealth App ...Aim: Develop and test efficacy of a novel mHealth app that will capitalize on smartphones' global positioning software that recognizes a user's ...
A Geospatial mHealth App for Gambling DisorderThe goal of this project is to develop and to test the efficacy of a novel mHealth app for gambling disorder. The app capitalizes on ...
mHealth App for Gambling AddictionResearch shows that mobile health apps can be effective in delivering cognitive behavioral therapy (CBT) for gambling problems, as they provide real-time ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36627464/
Mobile health (mHealth) interventions in prostate cancer ...This scoping review explores the application of mHealth technology in prostate cancer (CaP) management along the survivorship continuum.
Using a mHealth App to Improve Quality-of-Life Outcomes ...The purpose of this study is to test the effectiveness of a culturally appropriate and specific mobile app for ethnically diverse Black men with prostate cancer ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security